Skip to content
  • CAT
  • ESP
  • ENG
  • About us
  • Contact
El·lipse
  • instagram
  • twitter
  • flickr
  • linkdin
  • facebook
  • youtube
  • Research
  • Public engagement
  • Scientific life
  • Community
  • About us
  • Contact
  • instagram
  • twitter
  • flickr
  • linkdin
  • facebook
  • youtube
  • CAT
  • ESP
  • ENG

Clinical trials

16.12.2022

Treatment to improve cognitive function in Down’s syndrome on a clinical trial

Iris L. Matilla Vaz es enfermera en la unidad de investigación clínica del IMIM, donde se realizan ensayos clínicos en fase I.
20.05.2021

Iris Lioba Matilla Vaz (IMIM): “Without clinical trials, medicine could not move forward”

Several labs at the PRBB are joining forces to improve the lives of people with Sown Syndrome. Photo by Nathan Anderson on Unsplash
22.03.2021

Down Syndrome research at the PRBB

04.03.2021

Launched a clinical trial to prevent the side effects of COVID-19

23.02.2021

How do our genes influence our ability to overcome COVID-19?

17.02.2021

A clinical trial to verify the effectiveness of a new drug against COVID-19

05.02.2021

Maria Pia Cosma (CRG): “We want to maintain donors’ eyes alive for one month”

29.01.2021

Ivermectin could reduce viral transmission of COVID-19

27.01.2021

Wanted: volunteers to contribute to scientific progress

15.12.2020

Public-private collaboration to develop a treatment for fragile X syndrome

Ivermectin was recently shown to inhibit the replication of SARS-CoV-2 in vitro at very high doses, but this effect has not yet been studied in vivo. The new study will investigate this question in a randomised trial. | Picture by ISGlobal.
21.05.2020

New study to assess the efficacy of ivermectin against COVID-19

So far, two recent studies suggest that hydroxychloroquine may be effective in reducing the viral load of SARS-CoV-2, although the results are inconclusive and further research is needed.
13.05.2020

New study to assess the efficacy of hydroxychloroquine in the prevention and treatment of COVID-19 during pregnancy

El·lipse is published by the PRBB Communications and Corporate Relations Area.

Dr Aiguader, 88, 08003 Barcelona, Spain

For any suggestions or collaborations please contact us at ellipse@prbb.org

  • Read past print editions
  • About El·lipse
  • About the PRBB
  • Legal disclaimer
  • instagram
  • twitter
  • flickr
  • linkdin
  • facebook
  • youtube
© 2023 El·lipse, PRBB
  • Home
  • News
  • Our picks
This website uses cookies that provide us with personal information, such as data associated with your browsing. If you click on I AGREE, both we and our Partners can install cookies or access non-sensitive information on your device in order to facilitate the reproduction of content, provide features on social networks, create profiles and compile statistics on traffic and usability in our website. You can get MORE INFORMATION by accessing our COOKIES POLICY. I agree More information
Privacy & Cookies Policy
Necessary Always Enabled

Subscribe to our mailing list
Want to be the first to know everything that goes on at the biggest biomedical research hub in Southern Europe? Subscribe to the el·lipse newsletter!

We will send you an email with the latest news.

See you soon!

You are subscribing to receive the newsletter in English. If you would like to receive it in Catalan or Spanish, please change the language settings in our web.

PRBB will use the information you provide on this form to be in touch with you and to provide updates. By clicking below to subscribe, you accept our privacy policy. You can unsubscribe at any time.